We are the interdisciplinary experts

Our optimized diagnoses based on an extensive spectrum of methods help to extend life expectancy with improved quality of life.

To the diagnoses


The foundation for a specific therapy

Expertise, focus topics, state-of-the-art technology and tireless research – combined with our unwavering commitment to progress – guarantee optimized and individual diagnosis.

To the methods


  • 208
    Staff members
  • 708861
    Samples received since 2005
  • 549


MLL Münchner Leukämielabor GmbH

Max-Lebsche-Platz 31
81377 Munich

Telephone: +49 (0)89 99017-0
Fax: +49 (0)89 99017-111

Getting here

MLL Magazine

Stay up to date

Here you will find all MLL News as well as scientific contributions to leukemia diagnostics and research.

to the MLL Magazine

Current Articles

  • Dr. med. Christian Pohlkamp
    from 18.11.2019
    MLL News
    MLL develops an interactive PDF version of the test request form.

    Our understanding of the genetic changes underpinning malignant disease has expanded tremendously in the past few years. This is also reflected in the increasingly complex diagnostics on offer, particularly in the field of molecular genetics.

    Post review
    Read article
  • Dr. rer. nat. Sabine Jeromin
    from 16.11.2019
    Standardization of the BCR-ABL1 Quantification in CML

    When using molecular tests to quantify BCR-ABL1 in CML patients, it is recommended that the test be performed in a standardized laboratory. Standardization ensures that results comply with the ELN (European LeukemiaNet; Baccarani et al., Blood 2013) guidelines, enables comparisons to be made between laboratories and serves as quality assurance.

    Post review
    Read article


20.04.2020 - 24.04.2020
MLL Academy 2020

The next MLL Academy will be held from April 20th until April 24th, 2020. During the five-day workshop on the subject of “state of the art diagnostics in hematological malignancies“, participants can expect a mix of theoretical and practical content as well as joint discussions, all concerning the diagnosis of leukemias and lymphomas.

Read more

Newsletter registration

Sign up for our MLL News and receive information on latest findings in leukemia diagnostics and research. Newsletter only available in German.